OGFOD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.55111512312578E-16 |
Normal-vs-Stage2 |
1.71285208239169E-12 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.66666680456728E-12 |
Stage1-vs-Stage2 |
9.484200E-01 |
Stage1-vs-Stage3 |
1.297580E-01 |
Stage1-vs-Stage4 |
8.058400E-01 |
Stage2-vs-Stage3 |
3.036800E-01 |
Stage2-vs-Stage4 |
8.988800E-01 |
Stage3-vs-Stage4 |
2.093000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.33066907387547E-16 |
Normal-vs-AfricanAmerican |
4.44089209850063E-16 |
Normal-vs-Asian |
2.30439999999721E-05 |
Caucasian-vs-AfricanAmerican |
3.223400E-01 |
Caucasian-vs-Asian |
3.964600E-01 |
AfricanAmerican-vs-Asian |
2.068000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
5.55111512312578E-15 |
Male-vs-Female |
2.180200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.21374046766232E-12 |
Normal-vs-Age(41-60Yrs) |
2.1094237467878E-15 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
7.66570029675506E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.221200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.905200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.567000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.542300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.990400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.599200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.04039999948569E-07 |
Normal-vs-Grade 2 |
4.44089209850063E-16 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
8.04911692853238E-14 |
Grade 1-vs-Grade 2 |
9.940400E-01 |
Grade 1-vs-Grade 3 |
6.672000E-01 |
Grade 1-vs-Grade 4 |
7.612800E-01 |
Grade 2-vs-Grade 3 |
1.993190E-01 |
Grade 2-vs-Grade 4 |
4.794600E-01 |
Grade 3-vs-Grade 4 |
1.232410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62436730732907E-12 |
Normal-vs-ccB subtype |
4.30766533554561E-14 |
ccA subtype-vs-ccB subtype |
4.563600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62536650805123E-12 |
Normal-vs-N1 |
2.964100E-04 |
N0-vs-N1 |
2.240200E-01 |
|
|